Skip to main content
Top
Published in: Diabetologia 1/2007

01-01-2007 | Short Communication

Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trøndelag health study

Authors: S. Carlsson, K. Midthjell, M. Y. Tesfamarian, V. Grill

Published in: Diabetologia | Issue 1/2007

Login to get access

Abstract

Aims/hypothesis

Latent autoimmune diabetes (LADA) is a common form of diabetes, yet the risk factors are poorly characterised. The aim of this study was to investigate the influence of age, overweight and physical activity on the risk of LADA.

Methods

We analysed age, overweight and physical inactivity and the incidence of LADA in 38,800 men and women, observed between 1984 and 1986 and 1995 and 1997 as part of the Nord-Trøndelag Health Survey. We also compared such factors with incident cases of type 2 (n = 738) and ‘classic’ type 1 diabetes (n = 18). Patients classified as LADA (n = 81) had antibodies against GAD and were insulin independent at diagnosis.

Results

The proportion of those who were older, overweight and inactive before diagnosis was almost identical in LADA and type 2 diabetes patients. BMI ≥30 kg/m2 was strongly associated with LADA incidence (relative risk [RR] = 15.0, 95% CI 7.51–29.97). The association was similar for type 2 diabetes (RR = 15.37, 95% CI 12.07–19.57) but not for type 1 diabetes. Similarly, age (≥60 years) was an important risk factor for LADA (RR = 5.62, 95% CI 2.36–13.4) as well as for type 2 diabetes (RR = 6.78, 95% CI 5.07–9.06) in contrast to type 1 diabetes. Physical inactivity was associated with an increased risk of both LADA and type 2 diabetes.

Conclusions/interpretation

This study suggests that increased age, overweight and physical inactivity are as strong risk factors for LADA as for type 2 diabetes. These findings suggest a role for insulin resistance in the pathogenesis of LADA.
Literature
1.
go back to reference Fourlanos S, Dotta F, Greenbaum CJ et al (2005) Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:2206–2212PubMedCrossRef Fourlanos S, Dotta F, Greenbaum CJ et al (2005) Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:2206–2212PubMedCrossRef
2.
go back to reference Tuomi T, Carlsson A, Li H et al (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150–157PubMed Tuomi T, Carlsson A, Li H et al (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150–157PubMed
3.
go back to reference Zinman B, Kahn SE, Haffner SM, O’Neill MC, Heise MA, Freed MI; ADOPT Study Group (2004) Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 53:3193–3200PubMed Zinman B, Kahn SE, Haffner SM, O’Neill MC, Heise MA, Freed MI; ADOPT Study Group (2004) Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 53:3193–3200PubMed
4.
go back to reference Midthjell K, Bjørndal A, Holmen J, Krüger Ø, Bjartveit K (1995) Prevalence of known and previously unknown diabetes mellitus and glucose intolerance in an adult Norwegian population: indications of an increasing diabetes prevalence: the Nord-Trøndelag diabetes study. Scand J Prim Health Care 13:229–235PubMed Midthjell K, Bjørndal A, Holmen J, Krüger Ø, Bjartveit K (1995) Prevalence of known and previously unknown diabetes mellitus and glucose intolerance in an adult Norwegian population: indications of an increasing diabetes prevalence: the Nord-Trøndelag diabetes study. Scand J Prim Health Care 13:229–235PubMed
5.
go back to reference Midthjell K, Kruger O, Holmen J et al (1999) Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. Diabetes Care 22:1813–1820PubMed Midthjell K, Kruger O, Holmen J et al (1999) Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. Diabetes Care 22:1813–1820PubMed
6.
go back to reference Petersen JS, Hejnaes KR, Moody A et al (1994) Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459–467PubMed Petersen JS, Hejnaes KR, Moody A et al (1994) Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459–467PubMed
7.
go back to reference Fleiss JL (1981) Statistical methods for rates and proportions, 2nd edn. Wiley, New York, pp 75–77 Fleiss JL (1981) Statistical methods for rates and proportions, 2nd edn. Wiley, New York, pp 75–77
8.
go back to reference Wilkin TJ (2001) The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 44:914–922PubMedCrossRef Wilkin TJ (2001) The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 44:914–922PubMedCrossRef
9.
go back to reference Gale EA (2005) Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48:2195–2199PubMedCrossRef Gale EA (2005) Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48:2195–2199PubMedCrossRef
10.
go back to reference Carlsson S, Midthjell K, Grill V, Nord-Trøndelag Study (2004) Smoking is associated with an increased risk of type 2 diabetes but a decreased risk of autoimmune diabetes in adults: an 11-year follow-up of incidence of diabetes in the Nord-Trøndelag Study. Diabetologia 47:1953–1956PubMedCrossRef Carlsson S, Midthjell K, Grill V, Nord-Trøndelag Study (2004) Smoking is associated with an increased risk of type 2 diabetes but a decreased risk of autoimmune diabetes in adults: an 11-year follow-up of incidence of diabetes in the Nord-Trøndelag Study. Diabetologia 47:1953–1956PubMedCrossRef
Metadata
Title
Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trøndelag health study
Authors
S. Carlsson
K. Midthjell
M. Y. Tesfamarian
V. Grill
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 1/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0518-7

Other articles of this Issue 1/2007

Diabetologia 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.